slides · global inventory
Chart
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 78,129
Current window 22,501-22,530
Pages 2,605
Rows per page 30
Component
22,501-22,530 of 78,129
98
The slide uses two donut charts to visualize the sourcing mix.Hugo Boss | Investor Presentation Deck | 104 slides · Hugo Boss
Conference presentation Investor relations 2 hits
101
Hugo Boss | Investor Presentation Deck | 104 slidesHugo Boss | Investor Presentation Deck | 104 slides · Hugo Boss
Conference presentation Investor relations 2 hits
08
The slide uses a stacked bar chart to show margin vs cost and a donut chart to break down production costs, alongside a numbered list of strategic drivers.Hyzon | Results Presentation Deck | 15 slides · Hyzon
Conference presentation Investor relations 2 hits
14
The bar chart shows a clear trend of decreasing US revenue and increasing Offshore/Nearshore revenue over 2021-2023.IBEX | Investor Presentation Deck | 18 slides · ibex
Pitch deck Investor relations Beat · The Breakthrough2 hits
16
The slide uses two donut charts to show the percentage breakdown of revenue by industry vertical for two consecutive fiscal years.IBEX | Investor Presentation Deck | 18 slides · ibex
Pitch deck Investor relations Beat · Ultimate Achievement2 hits
13
IBEX | Results Presentation Deck | 25 slidesIBEX | Results Presentation Deck | 25 slides · ibex
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction2 hits
05
The slide uses a split-screen visual comparison to contrast traditional antibody approaches with the company's TCR-based platform.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · Problem2 hits
23
Includes waterfall plot for BOR and spider plot for response over time. Data cut-off Sep 30, 2023.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction2 hits
27
The slide uses two line charts to demonstrate the superior durability of CD4 T cells in a serial killing assay.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · Traction2 hits
30
Includes waterfall plot and spider plot (longitudinal response). Data cut-off Sep 30, 2023.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · Traction2 hits
43
The slide uses a bulleted list to define the therapeutic rationale and two line charts to provide empirical evidence.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Loop · Why Now2 hits
52
Includes study design timeline, histology details, and comparative tumor volume charts (group averages vs individual mice).Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 2 hits
71
Includes waterfall plot and spider plot for RECIST 1.1 response metrics.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 2 hits
72
Includes waterfall plot and spider plot (change in tumor size over time).Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 2 hits
47
Includes Kaplan-Meier survival curves and bioluminescence imaging of tumor activity.Immix Biopharma | Investor Presentation Deck | 60 slides · Immix Biopharma
Pitch deck Investor relations Loop · Golden Circle2 hits
52
Includes a comparative diagram of the drug molecule vs standard IgG antibody and multiple clinical/preclinical data charts.Immix Biopharma | Investor Presentation Deck | 60 slides · Immix Biopharma
Pitch deck Investor relations Loop · Golden Circle2 hits
53
Includes two sets of charts: tumor volume line graphs and survival curves for MDA-MB-231 and HCT-116 models.Immix Biopharma | Investor Presentation Deck | 60 slides · Immix Biopharma
Pitch deck Investor relations Loop · Golden Circle2 hits
54
Includes detailed scientific diagrams of the drug mechanism and clinical trial results.Immix Biopharma | Investor Presentation Deck | 60 slides · Immix Biopharma
Pitch deck Investor relations Loop · Golden Circle2 hits
51
Includes technical diagrams of the drug delivery vehicle and comparative histology/survival data.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action2 hits
52
Includes two sets of charts: tumor volume over time and survival curves.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action2 hits
53
Includes multiple citations and diagrams illustrating the mechanism of action and clinical efficacy.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action2 hits
25
Includes detailed clinical trial citations in the footer.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations Beat · Market Sizing2 hits
43
Includes survival curves (Kaplan-Meier style), median survival bar charts, and bioluminescence imaging of tumor activity.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations 2 hits
52
Includes a comparative size diagram of the drug vs IgG antibody and a Kaplan-Meier survival curve.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations 2 hits
53
Includes two distinct sets of preclinical charts (tumor volume and survival curves) with detailed methodology in footnotes.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations 2 hits
54
Includes multiple citations and diagrams illustrating the mechanism of action and clinical results.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations 2 hits
10
The slide uses stacked bar charts to show revenue composition across four segments: Data/Patient Network, Women's health, Rare diseases/Other, and Oncology.Invitae | Results Presentation Deck | 27 slides · Invitae
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction2 hits
09
The slide uses a dual-track timeline to show acquisitions (Luxury) vs divestments (Non-Luxury).Kering | Fixed Income Presentation Deck | 35 slides · Kering
Deck Investor relations Beat · Solution2 hits
33
The 2022 dividend is split into an interim payment and a balance payment.Kering | Fixed Income Presentation Deck | 35 slides · Kering
Deck Investor relations 2 hits
07
The slide uses a timeline to show the shift from non-luxury to luxury, and donut charts to illustrate the change in revenue composition.Kering | Investor Presentation Deck | 63 slides · Kering
Conference presentation Investor relations Beat · Situation & ContextLoop · Aha Moment2 hits